Leonardo DRS (DRS) Q4 2025 earnings review
Strong Demand Masked by Bipolar Segment Shocks
Leonardo DRS closed out 2025 with solid 13% annual revenue growth and a 1.2x book-to-bill ratio, fueled by robust defense spending. However, the headline Q4 results—8% revenue growth and 7% Adjusted EBITDA growth—hide massive underlying turbulence. The quarter's profitability was entirely saved by a $73 million windfall from a Quantum Laser IP license in the ASC segment. Without this, margins would have contracted sharply, dragged down by a $65 million charge to conclude a legacy foreign program in the IMS segment, which saw its margin crash to 1.7%. While 2026 guidance projects re-accelerating profit growth, the continued mention of 'higher material input costs' shows supply chain issues remain a lingering threat.
🐂 Bull Case
The company secured $4.2 billion in bookings for FY25, driving backlog to $8.7 billion (+3% YoY). The 1.2x book-to-bill ratio marks the fourth consecutive year achieving this benchmark, ensuring strong revenue visibility into 2026.
The $100M ($73M NPV) licensing agreement for quantum laser technology demonstrates that DRS possesses highly valuable, monetizable intellectual property that transcends traditional defense contracting.
🐻 Bear Case
The sudden $65 million Adjusted EBITDA hit from concluding a legacy foreign program is a stark reminder of fixed-price contract risks. It essentially wiped out the quarter's operating earnings for the entire IMS segment.
Even excluding the one-time charges, management explicitly cited 'less efficient program execution primarily driven by increased material input costs' as a drag on Q4 margins, indicating that supply chain inflation (likely tied to previous germanium constraints) remains a structural issue.
⚖️ Verdict: ⚪
Neutral. The macro tailwinds and backlog growth are undeniably strong. However, the quality of Q4 earnings is poor due to the heavy reliance on a one-time IP license to offset a massive execution failure on a legacy program. Investors need clarity on whether the IMS segment is fully de-risked.
Key Themes
IMS Margin Collapse from Legacy Contract
The Integrated Mission Systems (IMS) segment suffered a severe blow in Q4. Adjusted EBITDA plummeted 87% YoY to just $6 million, dragging the margin down from 14.1% a year ago to a dismal 1.7%. This Reversing trend was caused by a $65 million charge to conclude a legacy foreign ground surveillance program. This directly contradicts the management's broader narrative of 'exceptional execution' and highlights the lingering risks of complex, international fixed-price programs.
Quantum Laser IP License Distorts Results
The Advanced Sensing and Computing (ASC) segment reported a massive margin expansion in Q4, jumping to 21.1%. However, this was artificially inflated by a $73 million net present value recognition from a 10-year, $100 million IP licensing agreement for quantum computing applications. If we strip out this $73M windfall from both ASC revenue and EBITDA, the underlying ASC margin decelerated to approximately 12.1%, revealing that core operational profitability is actually under pressure.
Material Input Costs Continue to Bite
Throughout 2025, DRS struggled with supply chain constraints, notably the Chinese export restrictions on germanium, which squeezed ASC margins. The Q4 release confirms this remains a drag, citing 'increased material input costs' as a primary reason for less efficient program execution. This suggests that the cost-mitigation strategies (like recycling optics and alternative sourcing) are taking longer to implement than initially hoped.
Electric Power & Propulsion Strength
Despite the legacy program charge ruining Q4 segment optics, the core Electric Power and Propulsion business remains a massive growth engine. Management noted improved profitability on the Columbia Class program for the full year, and Q4 bookings in the IMS segment ($620M, 1.8x book-to-bill) were heavily driven by electric power demand, ensuring this remains a multi-year tailwind.
Resilient Defense Budget Alignment
DRS continues to benefit from an elevated global threat environment. Full-year bookings of $4.2 billion demonstrate that the company is effectively capturing funding from critical defense priorities, spanning tactical radars, counter-UAS (Force Protection), and naval network computing. This stable macro environment underpins the company's confident 2026 growth trajectory.
R&D Investments Diluting Margins
The company continues to fund internal research and development at an aggressive pace to stay ahead in AI, sensor fusion (SAGEcore/THOR), and unmanned systems. While strategically necessary, management noted that 'greater investment in internal research and development' kept full-year 2025 Adjusted EBITDA margins completely flat at 12.4%, offsetting the volume leverage they gained on the top line.
Other KPIs
Cash generation accelerated dramatically in the fourth quarter, delivering $376 million in FCF. This pulled the full-year FCF to $227 million (up from $190M in 2024), demonstrating the company's typical back-half weighted cash flow profile and fully supporting their dividend and share repurchase initiatives.
Backlog remains highly Stable, growing 3% year-over-year. The consistency of demand is impressive, marking the fourth consecutive year the company has achieved a book-to-bill ratio of 1.2x or better. This effectively de-risks the majority of the 2026 revenue target.
Guidance
Decelerating. The midpoint of $3.90 billion implies 6.9% year-over-year growth. While healthy for a defense prime, this represents a moderation from the 13% top-line growth achieved in 2025, likely reflecting base effects and a normalization of supply chain pull-ins.
Accelerating. The midpoint of $515 million implies 13.7% growth, vastly outpacing revenue growth. This indicates management expects significant margin expansion (implied ~13.2% vs 12.4% in 2025). Achieving this heavily relies on leaving the IMS legacy program write-downs and ASC material cost drags in the rearview mirror.
Decelerating. Implies approximately 7% growth at the midpoint compared to $1.15 in 2025. The slower growth relative to EBITDA is likely impacted by the slightly higher expected tax rate (18.5% guided vs 17.3% realized in 2025).
Key Questions
Legacy Program Risk Containment
Regarding the $67 million revenue and $65 million EBITDA hit in IMS for the legacy foreign ground surveillance program: Is this conclusion 100% finalized with no remaining tail liabilities, and are there any other legacy international fixed-price contracts in the portfolio with similar risk profiles?
Underlying ASC Margin Run-Rate
If we strip out the $73 million quantum laser IP license, ASC segment margins were pressured in Q4. How much of the 2026 margin expansion guidance relies on easing material input costs (like germanium), versus pricing actions or operating leverage?
Future IP Monetization
The $100M agreement to license laser technology to the commercial quantum computing sector is highly accretive. Do you view this as a one-off windfall, or is there a systematic strategy to commercialize other pockets of DRS's IP portfolio to adjacent industries?